Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 10 (ST13P10)
- Target
- ST13P10
- Molecular classification
- Pseudogene, Non-coding RNA (potentially, if it is transcribed, though no data specific to ST13P10 transcription exists), Other
01
Overview
ST13P10—Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 10—is a human pseudogene derived from the ST13 gene, which codes for a protein involved in Hsp70 chaperone function. As a pseudogene, ST13P10 is characterized by the loss of protein-coding capacity due to accumulated mutations and is generally considered nonfunctional at the protein level. There are no established biological functions, disease associations, or therapeutic targeting reported for ST13P10. While some pseudogenes in the human genome play regulatory roles at the RNA level, there is no current evidence for such a function in ST13P10 specifically.
- Other names
- ST13P10Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 10
02
Mechanism of action
None. There are no drugs targeting ST13P10.
03
Biological functions
No direct protein-coding or classic biological function; as a pseudogene, it may theoretically act through RNA-based regulatory mechanisms, but no direct evidence is available for ST13P10 specificallyGeneral pseudogene functions can include: Competing endogenous RNA ("ceRNA/sponging" microRNAs)General pseudogene functions can include: Gene expression regulation (paralog interaction), but this is not shown for ST13P10
04
Disease associations
None known for ST13P10 specificallyGeneral note: some pseudogenes are implicated in cancer and other diseases via RNA regulatory functions, but there is no evidence for this specific locusOther
05
Safety considerations
None, as this pseudogene is not targeted by any therapeutic agent.
06
Interacting drugs
None. No drugs are known or reported to directly interact with ST13P10 or pseudogenes in general.
07
Biomarkers
None. ST13P10 is not a reported biomarker.
Beyond the preview
Go deeper on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 10 (ST13P10).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 10 (ST13P10).